Bamboo Therapeutics' Acquisition

Bamboo Therapeutics was acquired by Pfizer on August 01, 2016.

Bamboo Therapeutics is an early-stage biotechnology company dedicated to developing gene therapies for orphan diseases. The gene therapy, initially called BMB-D001, has shown positive effects in Duche…

Articles about Bamboo Therapeutics' Acquisition: